Purchases and Sales Made in Q1 2025 in Aerovate Therapeutics, Inc. (AVTE)
This table provides information about the institutional ownership of Aerovate Therapeutics, Inc. (AVTE) during Q1 2025. The information is specifically focused on institutions that hold shares of Aerovate Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2025
Q1 2025
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-35K- 58.33% |
$83K - $94.5K
|
25K
$67K
|
|
|
May 15, 2025
Q1 2025
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-35.3K- 53.69% |
$83.6K - $95.2K
|
30.4K
$81.5K
|
|
|
May 15, 2025
Q1 2025
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-39.1K- 41.33% |
$92.7K - $106K
|
55.5K
$149K
|
|
|
May 21, 2025
Q1 2025
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-69.8K- 81.37% |
$165K - $188K
|
16K
$42.8K
|
|
|
May 15, 2025
Q1 2025
|
Morgan Stanley
New York, NY |
SELL
|
- |
-87.1K- 11.07% |
$206K - $235K
|
699K
$1.87M
|
|
|
May 14, 2025
Q1 2025
|
Group One Trading, L.P.
Chicago, IL |
SELL
|
- |
-103K- 73.51% |
$244K - $278K
|
37K
$99.3K
|